CLINICAL CASE OF TOCILIZUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

The article presents a case of successful use of a preparation of monoclonal antibodies to interleukin 6 receptors (tocilizumab) at asevere systemic juvenile idiopathic arthritis. Tocilizumab treatment promptly provided decrease of clinical and laboratory parametersof the disease activity, increase...

Full description

Saved in:
Bibliographic Details
Published inPediatricheskai͡a︡ farmakologii͡a︡ : nauchno-prakticheskiĭ zhurnal Soi͡u︡za pediatrov Rossii Vol. 11; no. 1; pp. 93 - 96
Main Authors O. L. Lomakina, E. I. Alexeyeva, R. V. Denisova, T. V. Sleptsova, A. N. Fetisova
Format Journal Article
LanguageRussian
Published Union of pediatricians of Russia 15.02.2014
Subjects
children
systemic juvenile idiopathic arthritis
tocilizumab
Online AccessGet full text

Cover

More Information
Summary:The article presents a case of successful use of a preparation of monoclonal antibodies to interleukin 6 receptors (tocilizumab) at asevere systemic juvenile idiopathic arthritis. Tocilizumab treatment promptly provided decrease of clinical and laboratory parametersof the disease activity, increase in the child’s physical activity, systemic juvenile idiopathic arthritis remission development and allowed avoiding per os prescription of glucocorticoids.
ISSN:1727-5776
2500-3089
DOI:10.15690/pf.v11i1.905